Numer badania | Tytuł badania | Nowotwór | Kategoria chorych | Faza badania | Sponsor badania | Data rozpoczęcia | Data zakończenia | Ośrodki badawcze | Sponsor badania | Linki |
---|---|---|---|---|---|---|---|---|---|---|
NCT00822614 | Safety of Fentanyl TAIFUN Treatment | choroba nowotworowa | ból przebijający | III | Akela Pharma | 2008-11-30 | 2009-12-31 |
Zbigniew Kaczmarek - Włocławek
|
Akela Pharma | |
NCT00937183 | Phase I/II Study of Adjuvant Dendritic Cell-Lymphoma Cell Hybrids and/or... | chłoniak B-komórkowy | bez progresji | II | CO-I Warszawa | 2003-08-31 | 2010-05-31 |
CO-I Warszawa, Jan Walewski, MD Ph: 48-22-546-2223 walewski@coi.waw.pl
|
CO-I Warszawa | |
NCT01185847 | A Study of RO5083945 in Combination With Chemotherapy Versus Chemotherapy... | rak płuca | ALK+ | II | Roche | 2010-10-31 | 2013-11-30 |
Łódź; Otwock
|
Roche | |
NCT01098266 | NGR015: Study in Second Line for Patient With Advanced Malignant... | międzybłoniak opłucnej | 1sza linia leczenia | III | MolMed | 2010-02-28 | 2013-01-31 |
UCK Gdańsk - Jacek Jassem; CO-I Warszawa - Paweł Badurak |
MolMed | |
NCT00646854 | Alemtuzumab and CHOP in T-cell Lymphoma | chłoniak T-kom | 1sza linia leczenia | III | Aarhus Universitetshospital | 2008-05-31 | 2016-11-30 |
CO-I Warszawa; prof.J.Walewski, walewski@coi.waw.pl
|
Aarhus Universitetshospital | |
NCT00209222 | Efficacy of Rituximab - Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP)... | chłoniak płaszcza | 1sza linia leczenia | III | University of Cologne | 2004-06-30 | 2010-05-31 |
Jan Walewski; Ph: +48-22-546-2223;
|
University of Cologne | |
NCT00209209 | Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus... | chłoniak płaszcza | 1. linia leczenia | III | University of Cologne | 2003-12-31 | 2013-12-31 |
CO-I Warszawa Jan Walewski; Ph: +48-22-546-2223; walewski@coi.waw.pl
|
University of Cologne | |
NCT01285609 | Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing... | rak płuca | 1. linia | III | BMS | 2011-05-31 | 2016-05-31 |
Elbląg; Gdańsk; Olsztyn; Szczecin
|
BMS | |
NCT00634049 | Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare... | przecigrzybicze leczenie | III | Astellas | 2008-03-31 | 2012-06-30 |
Warszawa
|
Astellas | ||
NCT01395017 | Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer | rak trzustki | II | Otsuka | 2011-05-31 | 2014-07-31 |
Lublin; Olsztyn
|
Otsuka |